| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.24B | +4.3% |
| Cost of Revenue | $246.0M | +6.5% |
| Gross Profit | $994.0M | +3.9% |
| R&D Expense | $97.0M | -9.3% |
| SG&A Expense | $634.0M | +2.6% |
| Operating Income | $262.0M | +718.8% |
| Interest Expense | $38.0M | +18.8% |
| Pre-tax Income | $239.0M | +1607.1% |
| Income Tax | $29.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $195.0M | -38.9% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $253.0M | -0.4% |
| Inventory | $153.0M | -14.0% |
| Current Assets | $652.0M | -22.3% |
| Total Assets | $1.20B | -8.9% |
| Current Liabilities | $914.0M | -2.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.0M | -175.0% |
| Capital Expenditures | $66.0M | +127.6% |
| Investing Cash Flow | -$66.0M | -195.7% |
| Financing Cash Flow | -$30.0M | +70.6% |
| Free Cash Flow | -$93.0M | -1428.6% |
| +163.6% |
| Net Income | $210.0M | — |
| EPS (Basic) | $1.68 | +8300.0% |
| EPS (Diluted) | $1.64 | +8100.0% |
| Long-term Debt |
| $290.0M |
| -7.9% |
| Total Liabilities | $1.30B | -22.1% |
| Stockholders' Equity | -$98.0M | +71.8% |